Marquardt R
Klin Monbl Augenheilkd. 1986 Jul;189(1):51-4. doi: 10.1055/s-2008-1050750.
Vidisic, a liquid gel derived from a polymerisate of acrylic acid for the treatment of dry eyes, was tested for 3 months in an open prospective study in 55 patients with severe dry eye. Vidisic spreads well over the cornea and conjunctiva and does not cause streaks. Compared with other tear substitutes so far available, Vidisic has a much longer viability, so that no more than 3 or 4 drops a day are necessary. Also, Vidisic is better tolerated and more effective. Moreover, there was a significant improvement, both subjectively and objectively, in the patients' conditions.
维迪西克是一种由丙烯酸聚合物制成的用于治疗干眼症的液体凝胶，在一项针对55例严重干眼症患者的开放性前瞻性研究中进行了为期3个月的测试。维迪西克能很好地覆盖在角膜和结膜上，不会产生条纹。与目前可用的其他泪液替代品相比，维迪西克的活性持续时间长得多，因此每天只需滴3至4次即可。此外，维迪西克的耐受性更好且更有效。而且，患者的病情在主观和客观上都有了显著改善。
